narcolepsy/RLS

0.0(0)
studied byStudied by 1 person
0.0(0)
full-widthCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/60

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

61 Terms

1
New cards

Typical age peaks for narcolepsy onset?

15 years and ~35 years.

2
New cards

What is the DSM-5 definition of narcolepsy?

Recurrent episodes of irresistible need to sleep or napping ≥3x/week for ≥3 months plus at least one of:

  1. Cataplexy (a few times per month).

  2. Hypocretin deficiency (low CSF).

  3. REM latency ≤15 min on PSG or MSLT with ≥2 sleep-onset REM periods.

3
New cards

How is narcolepsy severity rated?

  • Mild: Cataplexy <1/week.

  • Moderate: Cataplexy daily-every few days, disturbed sleep.

  • Severe: Multiple daily cataplexy attacks, constant sleepiness, resistant to meds.

4
New cards

What are the four classic symptoms (tetrad) of narcolepsy?

  • Excessive daytime sleepiness (EDS).

  • Cataplexy.

  • Hypnagogic/hypnopompic hallucinations.

  • Sleep paralysis.

5
New cards

Which symptom is present in nearly all narcolepsy patients?

Excessive daytime sleepiness (100%).

6
New cards

What autoimmune mechanism is thought to cause narcolepsy?

Destruction of hypocretin (orexin)-producing neurons.

7
New cards

What family history risk is associated with narcolepsy?

10–40× higher risk if first-degree relative affected.

8
New cards

What lifestyle strategies are recommended for narcolepsy?

  • Regular sleep schedule.

  • Avoid alcohol/CNS depressants.

  • Scheduled naps (10–30 min every 2h).

  • Use modest caffeine.

  • Avoid shift work.

  • Educate family/friends.

9
New cards

First-line treatment for EDS in narcolepsy?

Modafinil.

10
New cards

What are second-line options for EDS if modafinil not sufficient?

Dextroamphetamine, (dexedrine), Methylphenidate (Ritalin)

11
New cards

Newer alternatives for EDS in narcolepsy?

Solriamfetol, Pitolisant.

12
New cards

Efficacy of modafinil in narcolepsy?

A: Improves vigilance, ↓ daytime sleep episodes, little effect on nighttime sleep.

13
New cards

PK of modafinil?

Onset <1h, duration 6–8h.

14
New cards

Common adverse effects of modafinil?

↑ BP, headache, nausea, anxiety, insomnia, GI upset, dizziness.

15
New cards

Serious adverse effects of modafinil?

Rash (SJS), psychiatric symptoms (mania, psychosis, suicidality), cardiovascular events.

16
New cards

Efficacy of stimulants in narcolepsy?

Improve alertness, mood, daytime performance.

17
New cards

Adverse effects of stimulants?

↑ BP, HR, sweating, irritability, weight loss, insomnia, tolerance, risk of diversion.

18
New cards

Contraindications to stimulants?

Narrow angle glaucoma, hyperthyroidism, moderate-severe HTN, pheochromocytoma, symptomatic CVD, history of mania/psychosis.

19
New cards

Efficacy of solriamfetol?

↑ wakefulness duration slightly more than modafinil vs. placebo.

20
New cards

Adverse effects of solriamfetol?

↑ BP, tachycardia, headache, anxiety, insomnia, decreased appetite.

21
New cards

Contraindication for solriamfetol?

Avoid in unstable CVD, arrhythmias.

22
New cards

Efficacy of pitolisant?

May work as well as modafinil for EDS; modest cataplexy benefit.

23
New cards

MOA of pitolisant?

Histamine-3 receptor inverse agonist → ↑ histamine release in brain

24
New cards

Adverse effects of pitolisant?

Nausea, anxiety, insomnia, QT prolongation.

25
New cards

Q: Important drug interactions with pitolisant?

CYP2D6 inhibitors, CYP3A4 inducers, ↓ efficacy of hormonal contraceptives.

26
New cards

What are first-line treatments for cataplexy?

Sodium oxybate, pitolisant.

27
New cards

What antidepressants are commonly used off-label for cataplexy?

Venlafaxine, Clomipramine (TCAs > SSRIs).

28
New cards

Why should antidepressants for cataplexy be tapered gradually?

Abrupt discontinuation may cause rebound cataplexy or status cataplecticus.

29
New cards

MOA of sodium oxybate?

CNS depressant, GABA-B agonist, improves nocturnal sleep quality.

30
New cards

Efficacy of sodium oxybate in narcolepsy?

↓ cataplexy frequency/severity, ↑ daytime alertness.

31
New cards

Q: Major adverse effects of sodium oxybate?

Nausea, dizziness, sleepwalking, enuresis, disorientation, misuse potential, respiratory depression (boxed warning).

32
New cards

When should patients be followed up after treatment initiation?

4–6 weeks initially, then every 6–12 months.

33
New cards
34
New cards

Difference between primary and secondary RLS?

  • Primary: idiopathic, often familial (50% have + family history).

  • Secondary: due to conditions like iron deficiency, CKD, endocrine disorders, pregnancy, neuropathy.

35
New cards

Name key risk factors for RLS.

Older age, female sex, iron deficiency (<50 mcg/L), pregnancy, diabetes, hypothyroidism, MS, Parkinson’s, RA, CKD, vitamin deficiencies (B12, folate), electrolyte imbalances, venous insufficiency.

36
New cards

What is the hallmark feature of RLS?

Urge to move legs with uncomfortable sensations, worse at rest, relieved by movement, and more bothersome in evening/night.

37
New cards

What frequency and duration of symptoms od RLS meets DSM-5 criteria?

≥3 times per week for ≥3 months with functional impairment.

38
New cards

What mnemonic summarizes DSM-5 criteria for RLS?

URGE = Urge to move, Rest worsens, Getting up relieves, Evening symptoms.

39
New cards

What are periodic limb movements of sleep (PLMS)?

Forceful, repetitive leg jerks during sleep (occur in ~90% of RLS patients).

40
New cards

What labs should be ordered for suspected RLS?

BC, electrolytes, creatinine, thyroid, fasting glucose, vitamin B6/B12/folate, iron studies (serum iron, ferritin, iron saturation).

41
New cards

Name medications that can cause or worsen RLS.

Antidepressants (mirtazapine, TCAs, lithium, some SSRIs), antipsychotics, dopamine-blocking antiemetics (metoclopramide), antiepileptics (topiramate), sedating antihistamines, calcium channel blockers, alcohol, nicotine, caffeine, withdrawal from sedatives/opioids.

42
New cards

What are the treatment goals in RLS?

Improve motor restlessness & discomfort, improve sleep, reduce PLMS, improve daytime function, minimize rebound/augmentation from drug therapy.

43
New cards

Non-drug strategies for RLS?

Reduce alcohol/caffeine/nicotine, hot baths, stretching, exercise, massage, mental alertness activities, treat iron deficiency, stop offending meds, improve sleep hygiene.

44
New cards

What is first-line therapy if ferritin <75 mcg/L?

Oral iron supplementation.

45
New cards

First-line pharmacologic class for chronic RLS (≥3x/week)?

GABA analogues (gabapentin, pregabalin).

46
New cards

Which agents are 3rd line due to augmentation risk?

Dopamine agonists (pramipexole, ropinirole, rotigotine), levodopa/carbidopa.

47
New cards

What is recommended for intermittent RLS (<3x/week)?

Levodopa/carbidopa (PRN), low-dose opioids, or benzodiazepines.

48
New cards

Why are gabapentin/pregabalin often preferred for chronic RLS?

Good for insomnia, GAD, neuropathy, minimal augmentation risk.

49
New cards

Adverse effects of gabapentin/pregabalin?

Somnolence, dizziness, edema, weight gain (pregabalin).

50
New cards

Common dopamine agonists for RLS?

Pramipexole, ropinirole, rotigotine patch.

51
New cards

What is augmentation in RLS therapy?

Paradoxical worsening of symptoms (earlier onset, more severe, spread to trunk/arms).

52
New cards

What is rebound in RLS therapy?

Recurrence of symptoms late at night/early morning when drug effect wears off.

53
New cards

Adverse effects of dopamine agonists?

Orthostatic hypotension, hallucinations, somnolence, sudden sleep attacks, compulsive behaviors (gambling, hypersexuality).

54
New cards

Why is levodopa/carbidopa restricted to intermittent RLS use?

High risk of augmentation and rebound if used daily.

55
New cards

Adverse effects of levodopa/carbidopa?

Nausea, dizziness, orthostatic hypotension, dry mouth.

56
New cards

Q: What role do opioids play in RLS?

Low-potency opioids (e.g., codeine) may help refractory RLS, but risk dependence & sedation.

57
New cards

What role do benzodiazepines play in RLS?

A: Improve sleep quality but don’t treat core RLS symptoms; risk of sedation and dependence.

58
New cards

How is RLS managed in pregnancy?

Non-drug strategies and iron supplementation; avoid pharmacotherapy (none proven safe).

59
New cards

How is RLS managed in breastfeeding?

Non-drug strategies preferred; dopamine agonists suppress lactation; gabapentin may be considered if necessary.

60
New cards

what should be monitored with dopamine agonists?

Compulsive behaviors, augmentation.

61
New cards

What should be monitored with gabapentin/pregabalin?

Dizziness, falls.